captopril has been researched along with lithium chloride in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Blume, A; Culman, J; Gohlke, P; Kreutz, R; Rösch, N; Scholz, A; Unger, T; Xu, J | 1 |
| Fang, L; Gu, Z; Ma, P | 1 |
3 other study(ies) available for captopril and lithium chloride
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Low-dose lithium combined with captopril prevents stroke and improves survival in salt-loaded, stroke-prone spontaneously hypertensive rats.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Hypertension; Lithium; Lithium Chloride; Male; Potassium; Rats; Rats, Inbred SHR; Renin; Sodium; Sodium, Dietary; Stroke | 2005 |
The angiotensin-converting enzyme inhibitor, captopril, suppressed hepatic stellate cell activation via NF-kappaB or wnt3α/β-catenin pathway.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cell Line; Cell Survival; Glucose; Hepatic Stellate Cells; Lithium Chloride; NF-kappa B; Oxidative Stress; Phosphorylation; Rats; Signal Transduction; Tetradecanoylphorbol Acetate; Wnt3A Protein | 2021 |